Related Experiment Videos
Poor potential coverage for 7-valent pneumococcal conjugate vaccine, Malawi
Stephen B Gordon1, Stonard Kanyanda, Amanda L Walsh
1Wellcome Trust Research Laboratories, University of Malawi, Liverpool, UK. sgordon@mlw.medcol.mw
Emerging Infectious Diseases
|June 5, 2003
Summary
New conjugate vaccines help prevent Streptococcus pneumoniae infections but have limited serogroup coverage. Serogrouping data from Malawi shows a 9-valent vaccine could cover 66% of invasive pediatric isolates.
Area of Science:
- Medical Microbiology
- Vaccinology
- Epidemiology
Background:
- Streptococcus pneumoniae causes significant childhood and adult morbidity and mortality globally.
- Pneumococcal conjugate vaccines (PCVs) are effective but limited by serogroup coverage.
- Malawi faces a substantial burden of invasive pneumococcal disease.
Purpose of the Study:
- To determine the serogroup distribution of invasive and carried Streptococcus pneumoniae isolates in Malawi.
- To evaluate the potential impact of existing and next-generation pneumococcal conjugate vaccines in this population.
Main Methods:
- Collection of nasopharyngeal swabs and blood cultures from children and adults in Malawi.
- Serotyping of Streptococcus pneumoniae isolates using culture-based methods.
- Analysis of serotype coverage provided by 7-valent and 9-valent pneumococcal conjugate vaccines.
Main Results:
- The 7-valent PCV would cover 41% of invasive pediatric isolates and 25% of adult invasive isolates.
- A 9-valent PCV, including serotypes 1 and 5, demonstrated improved coverage.
- The 9-valent PCV would cover 66% of invasive pediatric isolates and 55% of adult invasive isolates.
Conclusions:
- Current pneumococcal conjugate vaccines offer suboptimal protection in Malawi.
- Expanding vaccine valency, particularly to include serotypes 1 and 5, significantly enhances coverage for invasive pneumococcal disease in Malawian children and adults.
- These findings support the need for vaccine strategies tailored to local serotype prevalence.